TPO-RA in Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 Years — ITP  

Primary Immune Thrombocytopenic Purpura Clinical Trial

Official title: Efficacy of TPO-RA in the Management of Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 Years With Poor First-line Response: a Multi-center, Prospective, One-arm Study

Status Recruiting

Clinical Trial Summary

This multi-center study aims to study the efficacy of TPO-RAs' transformation in Chinese ITP patients older than 14 years. This study will be conducted in ITP patients who had not responded to first-line in the previous treatment .

Clinical Trial Description

The primary objective of this study was to evaluate the efficacy of TPO-RAs' transformation in Chinese ITP patients older than 14 years who had not responded to first-line in the previous treatment.

100 eligible subjects will be enroll ed in this study.The dose will be adjusted according to the subject platelet count during the period from week 1 to week 6. ;

Related Conditions & MeSH terms

• Primary Immune Thrombocytopenic Purpura
• Purpura
• Purpura, Thrombocytopenic
• Purpura, Thrombocytopenic, Idiopathic
• Thrombocytopenia

• NCT number: NCT04890041
• Study type: Interventional
• Source: Institute of Hematology & Blood Diseases Hospital
• Contact: Wei Liu
• Phone: +82223909240
• Email: liuwei1@ihcams.ac.cn
• Status: Recruiting
• Phase: N/A
• Start date: May 30, 2021
• Completion date: December 31, 2023